Skip to content

Clinical Study on the effect of an Ayurvedic Treatment on diabetic mellitus patients having neuropathy in the limbs.

An Open Label Comparative Clinical Study To Assess The Effect Of Dasamoolaksheeradhara As An Add On Therapy With Standard Care In Conventional Medicine In Diabetic Neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/016983
Enrollment
100
Registered
2019-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Dasamoola Ksheera Dhara Treatment: External application once daily for 30 minutes 14 days along with conventional modern medicine. Control Intervention1: conventional modern medicine.:

Sponsors

Dr Anjaly NV
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of diabetic neuropathy fulfilling the diagnostic criteria. Patients having hemoglobin A1c(HbA1c) >6.5% at screening. Patient having FBS Patients currently treated with Standerd care in Modern medicine. Patient willing to give a signed informed consent form prior to start of the study.

Exclusion criteria

Exclusion criteria: Patient has hypersensitivity to any of the study medications Patient is a nursing mother, Pregnant. Patient has used injected anesthetics or steroids within 30 days of baseline. Known cases of Skinleisons, malignancy,, any non-diabetic neurologic disorders, seriouds health issues Patient has certain conditions that could confound evaluation of DPN, in particular, amputations other than toes, (e.g. phantom limb pain), and skin conditions affecting sensation in painful limbs. Patient has skin conditions in the area affected by the neuropathy that could alter sensation. Patient is in an immunocompromised state. Patient has any abnormal chemistry or hematology results that are deemed by the investigator to be clinically significant. Patient has a history of pernicious anemia, untreated hypothyroidism, chronic hepatitis B or C, hepatitis within the past 3 months, or HIV infection. Patient has any other serious medical condition.

Design outcomes

Primary

MeasureTime frame
Biothesio MeterTimepoint: Day 1,Day 15,Day 45

Secondary

MeasureTime frame
Blood Glucose LevelsTimepoint: Day 1,Day 15,Day 45;HbA1CTimepoint: Day 1,Day 45;Michigan Neuropathy Screening InstrumentTimepoint: Day 1,Day 15,Day 45;Neuropathy Total Symptom Score,Timepoint: Day 1,Day 15,Day 45;Quality of Life using Nottingham health profileTimepoint: Day 1,Day 15,Day 45

Countries

India

Contacts

Public ContactDrJayashamkar Mund

Mandsar University

principal.ayurved@meu.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026